Department of Nephrology, Toho University Faculty of Medicine, Tokyo, 143-8541, Japan.
Yamaguchi's Pathology Laboratory, Chiba, 270-2231, Japan.
Clin Exp Nephrol. 2019 Jun;23(6):799-806. doi: 10.1007/s10157-019-01709-6. Epub 2019 Feb 8.
We examined the clinicopathologic significance of hyalinosis in the vasa recta in the medulla of allograft kidney biopsies.
We analyzed biopsy specimens from January 2010 to December 2015, obtained from both the cortex and medulla (including the vasa recta) ≥ 1 year after living-donor kidney transplantation. We excluded biopsy specimens from recipients who had undergone transplantation due to diabetic nephropathy or who had diabetes mellitus after transplantation. We evaluated hyaline arteriolopathy in the cortex using the aah score determined by the Banff 2007 classification.
Among 381 biopsy specimens obtained from 248 transplant recipients ≥ 1 year after transplantation, 36 specimens obtained from 34 recipients showed vasa recta hyalinosis (VRH) in the medulla. Among these 36 specimens, 17 had a score of aah3, 16 had a score of aah2, and 3 had a score of aah1. The incidence of VRH was 1.9% at ≥ 1 to < 4 years, 7.1% at ≥ 4 to < 8 years, and 50.0% at ≥ 8 years. The aah scores and the proportion of hyalinosis in the arteriolar media among all muscular arterioles in the cortex were significantly higher in the VRH group at ≥ 8 years in the late-phase biopsy (P < 0.01). The graft survival was worse in the VRH group (P = 0.024), although there was no significant difference in the graft survival between the ≥ aah2 and < aah2 groups at ≥ 8 years in the late-phase biopsy (P = 0.159).
VRH in renal allografts reflects severe arteriolopathy of the cortex. VRH in the late-phase biopsy may be a prognostic factor for graft survival.
我们研究了同种异体肾移植活检中髓质直小血管玻璃样变的临床病理意义。
我们分析了 2010 年 1 月至 2015 年 12 月期间的活检标本,这些标本均来自活体供肾移植后 1 年以上的皮质和髓质(包括直小血管)。我们排除了因糖尿病肾病或移植后发生糖尿病而接受移植的受者的活检标本。我们使用 Banff 2007 分类确定的 aah 评分评估皮质中的透明小动脉病。
在 248 名移植受者的 381 份活检标本中,≥1 年后有 36 份标本显示髓质直小血管玻璃样变(VRH)。在这 36 份标本中,17 份标本的 aah3 评分,16 份标本的 aah2 评分,3 份标本的 aah1 评分。VRH 的发生率在≥1 至<4 年为 1.9%,在≥4 至<8 年为 7.1%,在≥8 年为 50.0%。在晚期活检中,VRH 组的 aah 评分和皮质中所有肌性小动脉中层中的玻璃样变性比例均显著高于≥8 年的其他组(P<0.01)。VRH 组的移植物存活率较差(P=0.024),尽管在晚期活检中≥aah2 和<aah2 组之间在≥8 年时移植物存活率没有显著差异(P=0.159)。
肾移植中 VRH 反映了皮质的严重小动脉病。晚期活检中的 VRH 可能是移植物存活率的预后因素。